Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna MRNA we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $1,051,700 and 2, calls, for a total amount of $85,619.
What’s The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $70.0 for Moderna over the recent three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 4201.44 with a total volume of 3,894.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna’s big money trades within a strike price range of $25.0 to $70.0 over the last 30 days.
Moderna 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 07/18/25 | $3.9 | $3.8 | $3.81 | $30.00 | $381.0K | 3.1K | 2.0K |
| MRNA | PUT | TRADE | BULLISH | 07/18/25 | $4.0 | $3.8 | $3.81 | $30.00 | $381.0K | 3.1K | 1.0K |
| MRNA | PUT | SWEEP | BEARISH | 09/19/25 | $7.9 | $7.85 | $7.85 | $35.00 | $102.8K | 6.7K | 169 |
| MRNA | CALL | SWEEP | BULLISH | 09/19/25 | $5.15 | $5.05 | $5.1 | $35.00 | $52.0K | 2.6K | 123 |
| MRNA | PUT | SWEEP | BEARISH | 09/19/25 | $2.6 | $2.59 | $2.6 | $25.00 | $46.8K | 6.6K | 196 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm’s mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Moderna
- With a volume of 1,954,007, the price of MRNA is up 0.1% at $31.51.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 35 days.
Professional Analyst Ratings for Moderna
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $36.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from Citigroup downgraded its action to Neutral with a price target of $40.
* Maintaining their stance, an analyst from JP Morgan continues to hold a Underweight rating for Moderna, targeting a price of $33.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
Momentum5.37
Growth–
Quality–
Value65.72
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
